NCT02891408View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

September 23, 2016

Primary Completion Date

May 5, 2019

Study Completion Date

May 13, 2019

Conditions

Nonalcoholic Steatohepatitis (NASH)

Interventions

DRUG

Firsocostat

Capsule(s) administered orally on Day 1

DRUG

Fenofibrate

Tablet administered orally on Day 1

Trial Locations (5)

Unknown

Tustin

Miami

Orlando

Minneapolis

San Antonio

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY